Literature DB >> 30338347

Hepatokines-a novel group of exercise factors.

Cora Weigert1,2,3, Miriam Hoene4, Peter Plomgaard5,6,7.   

Abstract

Regular physical activity not only improves the exercise capacity of the skeletal muscle performing the contractions, but it is beneficial for the whole body. An extensive search for "exercise factors" mediating these beneficial effects has been going on for decades. Particularly skeletal muscle tissue has been investigated as a source of circulating exercise factors, and several myokines have been identified. However, exercise also has an impact on other tissues. The liver is interposed between energy storing and energy utilising tissues and is highly active during exercise, maintaining energy homeostasis. Recently, a novel group of exercise factors-termed hepatokines-has emerged. These proteins (fibroblast growth factor 21, follistatin, angiopoietin-like protein 4, heat shock protein 72, insulin-like growth factor binding protein 1) are released from the liver and increased in the bloodstream during or in the recovery after an exercise bout. In this narrative review, we evaluate this new group of exercise factors focusing on the regulation and potential function in exercise metabolism and adaptations. These hepatokines may convey some of the beneficial whole-body effects of exercise that could ameliorate metabolic diseases, such as obesity or type 2 diabetes.

Entities:  

Keywords:  ANGPTL4; Energy metabolism; Exercise; FGF21; Follistatin; HSP72; Hepatokines; IGFBP; Insulin resistance; Liver; Selenoprotein P; Training; Type 2 diabetes

Mesh:

Substances:

Year:  2018        PMID: 30338347     DOI: 10.1007/s00424-018-2216-y

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  131 in total

1.  Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease.

Authors:  Jody Dushay; Patricia C Chui; Gosala S Gopalakrishnan; Marta Varela-Rey; Meghan Crawley; Ffolliott M Fisher; Michael K Badman; Maria L Martinez-Chantar; Eleftheria Maratos-Flier
Journal:  Gastroenterology       Date:  2010-05-05       Impact factor: 22.682

2.  Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member.

Authors:  A C McPherron; A M Lawler; S J Lee
Journal:  Nature       Date:  1997-05-01       Impact factor: 49.962

Review 3.  The stress response of the liver to physical exercise.

Authors:  Miriam Hoene; Cora Weigert
Journal:  Exerc Immunol Rev       Date:  2010       Impact factor: 6.308

4.  Follistatin inactivation improves glucose tolerance.

Authors:  Ivone Leong
Journal:  Nat Rev Endocrinol       Date:  2018-08       Impact factor: 43.330

Review 5.  Circulating follistatin in relation to energy metabolism.

Authors:  Jakob Schiøler Hansen; Peter Plomgaard
Journal:  Mol Cell Endocrinol       Date:  2016-06-02       Impact factor: 4.102

6.  Hsp72 preserves muscle function and slows progression of severe muscular dystrophy.

Authors:  Stefan M Gehrig; Chris van der Poel; Timothy A Sayer; Jonathan D Schertzer; Darren C Henstridge; Jarrod E Church; Severine Lamon; Aaron P Russell; Kay E Davies; Mark A Febbraio; Gordon S Lynch
Journal:  Nature       Date:  2012-04-04       Impact factor: 49.962

7.  A phase 1/2a follistatin gene therapy trial for becker muscular dystrophy.

Authors:  Jerry R Mendell; Zarife Sahenk; Vinod Malik; Ana M Gomez; Kevin M Flanigan; Linda P Lowes; Lindsay N Alfano; Katherine Berry; Eric Meadows; Sarah Lewis; Lyndsey Braun; Kim Shontz; Maria Rouhana; Kelly Reed Clark; Xiomara Q Rosales; Samiah Al-Zaidy; Alessandra Govoni; Louise R Rodino-Klapac; Mark J Hogan; Brian K Kaspar
Journal:  Mol Ther       Date:  2014-10-17       Impact factor: 11.454

8.  Circulating FGF-21 levels in normal subjects and in newly diagnose patients with Type 2 diabetes mellitus.

Authors:  W-W Chen; L Li; G-Y Yang; K Li; X-Y Qi; W Zhu; Y Tang; H Liu; G Boden
Journal:  Exp Clin Endocrinol Diabetes       Date:  2007-10-09       Impact factor: 2.949

9.  Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy.

Authors:  Savalan Babapoor-Farrokhran; Kathleen Jee; Brooks Puchner; Syed Junaid Hassan; Xiaoban Xin; Murilo Rodrigues; Fabiana Kashiwabuchi; Tao Ma; Ke Hu; Monika Deshpande; Yassine Daoud; Sharon Solomon; Adam Wenick; Gerard A Lutty; Gregg L Semenza; Silvia Montaner; Akrit Sodhi
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-26       Impact factor: 11.205

10.  Circulating FGF21 is liver derived and enhances glucose uptake during refeeding and overfeeding.

Authors:  Kathleen R Markan; Meghan C Naber; Magdalene K Ameka; Maxwell D Anderegg; David J Mangelsdorf; Steven A Kliewer; Moosa Mohammadi; Matthew J Potthoff
Journal:  Diabetes       Date:  2014-07-09       Impact factor: 9.461

View more
  14 in total

Review 1.  Metabolic communication during exercise.

Authors:  Robyn M Murphy; Matthew J Watt; Mark A Febbraio
Journal:  Nat Metab       Date:  2020-08-03

Review 2.  The Role of Exercise in the Interplay between Myokines, Hepatokines, Osteokines, Adipokines, and Modulation of Inflammation for Energy Substrate Redistribution and Fat Mass Loss: A Review.

Authors:  Adrian M Gonzalez-Gil; Leticia Elizondo-Montemayor
Journal:  Nutrients       Date:  2020-06-26       Impact factor: 5.717

3.  Comment on: "Fibroblast growth factor 21 controls mitophagy and muscle mass" by Oost et al.

Authors:  Yeshun Wu; Bin Zhu; Zijun Chen; Jiahao Duan; Ling Yang
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-07-15       Impact factor: 12.910

4.  Effect of mountain ultra-marathon running on plasma angiopoietin-like protein 4 and lipid profile in healthy trained men.

Authors:  Monika Górecka; Krzysztof Krzemiński; Monika Buraczewska; Agnieszka Kozacz; Jan Dąbrowski; Andrzej Wojciech Ziemba
Journal:  Eur J Appl Physiol       Date:  2019-11-09       Impact factor: 3.078

Review 5.  Muscle-Organ Crosstalk: The Emerging Roles of Myokines.

Authors:  Mai Charlotte Krogh Severinsen; Bente Klarlund Pedersen
Journal:  Endocr Rev       Date:  2020-08-01       Impact factor: 19.871

6.  Reduced Oxidative Stress and Enhanced FGF21 Formation in Livers of Endurance-Exercised Rats with Diet-Induced NASH.

Authors:  Janin Henkel; Katja Buchheim-Dieckow; José P Castro; Thomas Laeger; Kristina Wardelmann; André Kleinridders; Korinna Jöhrens; Gerhard P Püschel
Journal:  Nutrients       Date:  2019-11-08       Impact factor: 5.717

7.  Muscle-Liver Substrate Fluxes in Exercising Humans and Potential Effects on Hepatic Metabolism.

Authors:  Chunxiu Hu; Miriam Hoene; Peter Plomgaard; Jakob S Hansen; Xinjie Zhao; Jia Li; Xiaolin Wang; Jens O Clemmesen; Niels H Secher; Hans U Häring; Rainer Lehmann; Guowang Xu; Cora Weigert
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

Review 8.  Physiopathology of Lifestyle Interventions in Non-Alcoholic Fatty Liver Disease (NAFLD).

Authors:  David Carneros; Guillermo López-Lluch; Matilde Bustos
Journal:  Nutrients       Date:  2020-11-12       Impact factor: 5.717

9.  Constitutive PGC-1α Overexpression in Skeletal Muscle Does Not Contribute to Exercise-Induced Neurogenesis.

Authors:  Lars Karlsson; María Nazareth González-Alvarado; Reza Motalleb; Yafeng Wang; Yong Wang; Mats Börjesson; Changlian Zhu; Hans-Georg Kuhn
Journal:  Mol Neurobiol       Date:  2020-11-16       Impact factor: 5.590

10.  Spinal Cord Injury Reduces Serum Levels of Fibroblast Growth Factor-21 and Impairs Its Signaling Pathways in Liver and Adipose Tissue in Mice.

Authors:  Xin-Hua Liu; Zachary A Graham; Lauren Harlow; Jiangping Pan; Daniella Azulai; William A Bauman; Joshua Yarrow; Christopher P Cardozo
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-11       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.